{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:31Z","timestamp":1792788571870,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polidocanol foam sclerotherapy has gained increasing attention as a minimally invasive treatment for hemorrhoidal disease (HD). However, significant variability exists in its clinical application regarding patient selection, procedural techniques, and postoperative management. This study aimed to assess real-world practice patterns among international experts, summarize existing evidence through a systematic literature review, and develop evidence-based clinical practice recommendations. A systematic review was conducted in MEDLINE, EMBASE, and CENTRAL to identify studies evaluating polidocanol foam sclerotherapy for HD. A total of 20 studies met the inclusion criteria. Additionally, an international survey was distributed to 30 experts in proctology and colorectal surgery to explore variations in indications, perioperative management, technique, and follow-up. Survey responses were analyzed descriptively to identify common trends and areas of divergence. Subsequently, based on both the experts\u2019 opinions and the results of the survey, a Delphi method was employed to produce clinical practice recommendations. The questions for the Delphi process were developed by the authors leading the project, followed by a detailed discussion with the whole panel of experts. Most experts (90%) reported using polidocanol foam sclerotherapy primarily for Goligher grade II HD, with 67% extending its use to grade III cases. Preoperative bowel preparation and anesthesia use varied widely. The preferred concentration was 3% polidocanol, with 2\u00a0mL injected per hemorrhoidal pile in most cases. Post-procedural care lacked standardization, though stool softeners and flavonoids were commonly recommended. Compared to rubber band ligation, polidocanol foam was perceived as having higher success rates (88.3% vs. 66.7%) and lower recurrence rates (16.1% vs. 41.2%). Adverse events were infrequent. The present article offers a comprehensive suite of clinical practice expert-based recommendations concerning the use of polidocanol foam sclerotherapy for HD. However, there is still significant variation in its application. These findings highlight the need for standardized guidelines and further research to optimize procedural strategies and long-term outcomes.<\/jats:p>","DOI":"10.1007\/s13304-025-02258-2","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:27:55Z","timestamp":1749212875000},"page":"1439-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Real-world use of polidocanol foam sclerotherapy for hemorrhoidal disease: insights from an international survey and systematic review with clinical practice recommendations"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-4671","authenticated-orcid":false,"given":"Gaetano","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-1111","authenticated-orcid":false,"given":"Arcangelo","family":"Picciariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Diaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Laforgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Lobascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"De Parades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Realis Luc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Salgueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Trompetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Tutino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Sileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Gravante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2258_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3393\/ac.2020.02.06","volume":"36","author":"CW Sobrado Junior","year":"2020","unstructured":"Sobrado J\u00fanior CW, Obregon CA, E Sousa J\u00fanior AHDS, Sobrado LF, Nahas SC, Cecconello I (2020) A new classification for hemorrhoidal disease: the creation of the \u201cBPRST\u201d staging and its application in clinical practice. Ann Coloproctol 36(4):249\u2013255. https:\/\/doi.org\/10.3393\/ac.2020.02.06. Epub 2020 Jun 1. PMID: 32674550; PMCID: PMC7508483","journal-title":"Ann Coloproctol"},{"key":"2258_CR2","first-page":"10","volume":"16","author":"A Picciariello","year":"2021","unstructured":"Picciariello A, Tsarkov PV, Papagni V, Efetov S, Markaryan DR, Tulina I, Altomare DF (2021) Classifications and clinical assessment of haemorrhoids: the proctologist\u2019s corner. Rev Recent Clin Trials 16:10\u201316","journal-title":"Rev Recent Clin Trials"},{"key":"2258_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10151-020-02149-1","volume":"24","author":"G Gallo","year":"2020","unstructured":"Gallo G, Martellucci J, Sturiale A, Clerico G, Milito G, Marino F, Cocorullo G, Giordano P, Mistrangelo M, Trompetto M (2020) Consensus statement of the Italian Society of Colorectal Surgery (SICCR): management and treatment of hemorrhoidal disease. Tech Coloproctol 24:145\u2013164","journal-title":"Tech Coloproctol"},{"key":"2258_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10151-022-02640-x","volume":"26","author":"V de Parades","year":"2022","unstructured":"de Parades V, Aubert M, Fathallah N, Alam AA, Spindler L, Benfredj P (2022) The comeback of hemorrhoidal sclerotherapy? Tech Coloproctol 26:599\u2013601","journal-title":"Tech Coloproctol"},{"key":"2258_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10350-004-0921-4","volume":"48","author":"P Cataldo","year":"2005","unstructured":"Cataldo P, Ellis CN, Gregorcyk S, Hyman N, Buie WD, Church J, Cohen J, Fleshner P, Kilkenny J 3rd, Ko C, Levien D, Nelson R, Newstead G, Orsay C, Perry WB, Rakinic J, Shellito P, Strong S, Ternent C, Tjandra J, Whiteford M (2005) Practice parameters for the management of hemorrhoids (revised). Dis Colon Rectum 48:189\u2013194","journal-title":"Dis Colon Rectum"},{"key":"2258_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/codi.14339","volume":"20","author":"DF Altomare","year":"2018","unstructured":"Altomare DF, Picciariello A, Pecorella G, Milito G, Naldini G, Amato A, Ratto C, Perinotti R (2018) Surgical management of haemorrhoids: an Italian survey of over 32000 patients over 17 years. Colorectal Dis 20:1117\u20131124","journal-title":"Colorectal Dis"},{"key":"2258_CR7","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1517\/13543780903376163","volume":"18","author":"DM Eckmann","year":"2009","unstructured":"Eckmann DM (2009) Polidocanol for endovenous microfoam sclerosant therapy. Expert Opin Investig Drugs 18:1919\u20131927","journal-title":"Expert Opin Investig Drugs"},{"key":"2258_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00384-013-1729-2","volume":"28","author":"KH Moser","year":"2013","unstructured":"Moser KH, Mosch C, Walgenbach M, Bussen DG, Kirsch J, Joos AK, Gliem P, Sauerland S (2013) Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial. Int J Colorectal Dis 28:1439\u20131447","journal-title":"Int J Colorectal Dis"},{"key":"2258_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5152\/tjg.2020.19276","volume":"31","author":"S Mishra","year":"2020","unstructured":"Mishra S, Sahoo AK, Elamurugan TP, Jagdish S (2020) Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: a randomized controlled trial. Turk J Gastroenterol 31:378\u2013383","journal-title":"Turk J Gastroenterol"},{"key":"2258_CR10","doi-asserted-by":"crossref","unstructured":"Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 29:1170\u20131175; discussion 1175","DOI":"10.1111\/j.1524-4725.2003.29398.x"},{"key":"2258_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.782800","volume":"8","author":"R Tutino","year":"2022","unstructured":"Tutino R, Massani M, Jospin Kamdem Mambou L, Venturelli P, Della Valle I, Melfa G, Micheli M, Russo G, Scerrino G, Bonventre S, Cocorullo G (2022) A stepwise proposal for low-grade hemorrhoidal disease: injection sclerotherapy as a first-line treatment and rubber band ligation for persistent relapses. Front Surg 8:782800","journal-title":"Front Surg"},{"key":"2258_CR12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i8.98704","volume":"31","author":"G Gravante","year":"2025","unstructured":"Gravante G (2025) Sclerotherapy for hemorrhoidal disease: recent evolutions of an oldies goldy. World J Gastroenterol 31:98704","journal-title":"World J Gastroenterol"},{"key":"2258_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"2258_CR14","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G (2004) Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 6:e34","journal-title":"J Med Internet Res"},{"key":"2258_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ecns.2022.04.009","volume":"68","author":"P Bridge","year":"2022","unstructured":"Bridge P, Adeoye J, Edge CN, Garner VL, Sharp J (2022) Simulated placements as a partial replacement of clinical training time: a Delphi consensus study. Clin Simul Nurs 68:42\u201348","journal-title":"Clin Simul Nurs"},{"key":"2258_CR16","volume":"6","author":"M Ronconi","year":"2018","unstructured":"Ronconi M, Casiraghi S, Schieppati M (2018) EndoTHeF: endoluminal treatment of hemorrhoids with foam. Ann Colorectal Res 6:e86297","journal-title":"Ann Colorectal Res"},{"key":"2258_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000492202","volume":"26","author":"V Fernandes","year":"2019","unstructured":"Fernandes V, Fonseca J (2019) Polidocanol foam injected at high doses with intravenous needle: the (almost) perfect treatment of symptomatic internal hemorrhoids. GE Port J Gastroenterol 26:169\u2013175","journal-title":"GE Port J Gastroenterol"},{"key":"2258_CR18","first-page":"917","volume":"12","author":"F Shen","year":"2019","unstructured":"Shen F, Qu C, Zhang Y, Zhou M, Deng Z, Zhu H, Zhu J, Chen G, Zhang X, Xu L (2019) Therapeutic effects of endoscopic foam sclerotherapy for bleeding internal hemorrhoids. Chin J Dig Endosc 12:917\u2013922","journal-title":"Chin J Dig Endosc"},{"issue":"4","key":"2258_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/npmj.npmj_232_20","volume":"27","author":"A Makanjuola","year":"2020","unstructured":"Makanjuola A, Balogun OS, Osinowo AO, Adesanya AA, da Rocha JT (2020) Comparison of rubber band ligation with 3% polidocanol injection sclerotherapy for the treatment of internal haemorrhoids at a Nigerian tertiary hospital. Niger Postgrad Med J 27(4):311\u2013316. https:\/\/doi.org\/10.4103\/npmj.npmj_232_20","journal-title":"Niger Postgrad Med J"},{"key":"2258_CR20","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.18203\/2349-2902.isj20203769","volume":"7","author":"S Shekhar","year":"2020","unstructured":"Shekhar S, Gupta VK (2020) Efficacy of foam sclerotherapy in treatment of grade I and grade II bleeding hemorrhoids at Nalanda Medical College and Hospital. Patna Int Surg J 7:2925\u20132928","journal-title":"Patna Int Surg J"},{"key":"2258_CR21","doi-asserted-by":"publisher","DOI":"10.26689\/jcnr.v4i6.1628","author":"Y Qi","year":"2020","unstructured":"Qi Y, Zhou F, Geng Z, Liu L (2020) Clinical observation of the treatment of hemorrhoids with polyvinyl alcohol foam sclerotherapy under transparent cap assisted endoscope. J Clin Res Nurs. https:\/\/doi.org\/10.26689\/jcnr.v4i6.1628","journal-title":"J Clin Res Nurs"},{"key":"2258_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010218","author":"F Pata","year":"2022","unstructured":"Pata F, Bracchitta LM, D\u2019Ambrosio G, Bracchitta S (2022) Sclerobanding (combined rubber band ligation with 3% polidocanol foam sclerotherapy) for the treatment of second- and third-degree hemorrhoidal disease: feasibility and short-term outcomes. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11010218","journal-title":"J Clin Med"},{"key":"2258_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/08941939.2020.1745964","volume":"34","author":"P Lobascio","year":"2021","unstructured":"Lobascio P, Laforgia R, Novelli E, Perrone F, Di Salvo M, Pezzolla A, Trompetto M, Gallo G (2021) Short-term results of sclerotherapy with 3% polidocanol foam for symptomatic second- and third-degree hemorrhoidal disease. J Invest Surg 34:1059\u20131065","journal-title":"J Invest Surg"},{"key":"2258_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00384-021-03848-3","volume":"36","author":"G Lisi","year":"2021","unstructured":"Lisi G, Campanelli M, Grande S, Milito G, Grande M (2021) Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as \u201cbridge treatment\u201d during the COVID-19 pandemic in Italy. Int J Colorectal Dis 36:1321\u20131322","journal-title":"Int J Colorectal Dis"},{"key":"2258_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.882030","volume":"9","author":"M Goglia","year":"2022","unstructured":"Goglia M, Nigro C, Aurello P, Diaco E, Trompetto M, Gallo G (2022) Preliminary results of the first 50 patients undergoing sclerotherapy for II-degree hemorrhoidal disease using an automated device. Front Surg 9:882030","journal-title":"Front Surg"},{"key":"2258_CR26","doi-asserted-by":"publisher","first-page":"e718","DOI":"10.1097\/DCR.0000000000002117","volume":"65","author":"P Salgueiro","year":"2022","unstructured":"Salgueiro P, Garrido M, Santos RG, Pedroto I, Castro-Po\u00e7as FM (2022) Polidocanol foam sclerotherapy versus rubber band ligation in hemorrhoidal disease grades I\/II\/III: randomized trial. Dis Colon Rectum 65:e718\u2013e727","journal-title":"Dis Colon Rectum"},{"key":"2258_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10151-022-02600-5","volume":"26","author":"P Salgueiro","year":"2022","unstructured":"Salgueiro P, Rei A, Garrido M, Rosa B, Oliveira AM, Pereira-Guedes T, Morais S, Castro-Po\u00e7as F (2022) Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study. Tech Coloproctol 26:615\u2013625","journal-title":"Tech Coloproctol"},{"key":"2258_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10151-022-02609-w","volume":"26","author":"G Gallo","year":"2022","unstructured":"Gallo G, Pietroletti R, Novelli E, Sturiale A, Tutino R, Lobascio P, Laforgia R, Moggia E, Pozzo M, Roveroni M, Bianco V, Luc AR, Giuliani A, Diaco E, Naldini G, Trompetto M, Perinotti R, Sammarco G (2022) A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM). Tech Coloproctol 26:627\u2013636","journal-title":"Tech Coloproctol"},{"key":"2258_CR29","first-page":"185","volume":"114","author":"LM Figueiredo","year":"2022","unstructured":"Figueiredo LM, Bordalo Ferreira F, Rafael MA, Oliveira AM (2022) Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease\u2014a single-center experience. Rev Esp Enferm Dig 114:185\u2013186","journal-title":"Rev Esp Enferm Dig"},{"key":"2258_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/codi.16380","volume":"25","author":"G Gallo","year":"2023","unstructured":"Gallo G, Picciariello A, Pietroletti R, Novelli E, Sturiale A, Tutino R, Laforgia R, Moggia E, Pozzo M, Roveroni M, Bianco V, Realis Luc A, Giuliani A, Diaco E, Naldini G, Trompetto M, Perinotti R, D\u2019Andrea V, Lobascio P (2023) Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: three-year follow-up of a multicentre, single-arm, IDEAL phase 2b trial. Colorectal Dis 25:386\u2013395","journal-title":"Colorectal Dis"},{"key":"2258_CR31","doi-asserted-by":"publisher","first-page":"1290706","DOI":"10.3389\/fsurg.2023.1290706","volume":"10","author":"F Pata","year":"2023","unstructured":"Pata F, Bracchitta LM, Nardo B, Gallo G, D\u2019Ambrosio G, Bracchitta S (2023) Sclerobanding in the treatment of second and third degree hemorrhoidal disease in high-risk patients on antiplatelet\/anticoagulant therapy without suspension: a pilot study. Front Surg 10:1290706","journal-title":"Front Surg"},{"key":"2258_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2023.1151327","volume":"10","author":"P Lobascio","year":"2023","unstructured":"Lobascio P, Laforgia R, Pezzolla A (2023) Results of sclerotherapy and mucopexy with haemorrhoidal dearterialization in II and III degree haemorrhoids. A 4 years\u2019 single centre experience. Front Surg 10:1151327","journal-title":"Front Surg"},{"key":"2258_CR33","first-page":"115","volume":"115","author":"S Neves","year":"2023","unstructured":"Neves S, Falc\u00e3o D, Povo A, Castro-Po\u00e7as F, Oliveira J, Salgueiro P (2023) 3% Polidocanol foam sclerotherapy versus hemorrhoidal artery ligation with recto-anal repair in hemorrhoidal disease grades II-III: a randomized, pilot trial. Rev Esp Enferm Dig 115:115\u2013120","journal-title":"Rev Esp Enferm Dig"},{"key":"2258_CR34","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.3748\/wjg.v30.i27.3326","volume":"30","author":"CY Qu","year":"2024","unstructured":"Qu CY, Zhang FY, Wang W, Gao FY, Lin WL, Zhang H, Chen GY, Zhang Y, Li MM, Li ZH, Cai MH, Xu LM, Shen F (2024) Endoscopic polidocanol foam sclerobanding for the treatment of grade II-III internal hemorrhoids: a prospective, multi-center, randomized study. World J Gastroenterol 30:3326\u20133335","journal-title":"World J Gastroenterol"},{"key":"2258_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/ped.14506","volume":"63","author":"T Watanabe","year":"2021","unstructured":"Watanabe T, Ohno M, Tahara K, Tomonaga K, Ogawa K, Takezoe T, Fuchimoto Y, Fujino A, Kanamori Y (2021) Efficacy and safety of sclerotherapy with polidocanol in children with internal hemorrhoids. Pediatr Int 63:813\u2013817","journal-title":"Pediatr Int"},{"key":"2258_CR36","first-page":"702","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Xiao Y, Li J, Cao Z, Luo H, Chen M (2021) Therapeutic effects of different endoscopic strategies on grade I-III internal hemorrhoids: a single-center retrospective study. Chin J Dig Endosc 12:702\u2013706","journal-title":"Chin J Dig Endosc"},{"key":"2258_CR37","first-page":"235","volume":"62","author":"P Benin","year":"2007","unstructured":"Benin P, D\u2019Amico C (2007) Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope. Minerva Chir 62:235\u2013240","journal-title":"Minerva Chir"},{"key":"2258_CR38","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s13304-021-01008-4","volume":"73","author":"G Gallo","year":"2021","unstructured":"Gallo G, Ronconi M, Trompetto M (2021) Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease. Updates Surg 73:2029\u20132030","journal-title":"Updates Surg"},{"key":"2258_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113078","author":"F Pata","year":"2022","unstructured":"Pata F, Bracchitta LM, D\u2019Ambrosio G, Bracchitta S (2022) Sclerobanding is a novel technique for the treatment of second- and third-degree hemorrhoidal disease. Reply to Jongen et al. Comment on \u201cPata et al. Sclerobanding (combined rubber band ligation with 3% polidocanol foam sclerotherapy) for the treatment of second- and third-degree hemorrhoidal disease: feasibility and short-term outcomes. J. Clin. Med. 2022, 11, 218.\u201d J Clin Med. https:\/\/doi.org\/10.3390\/jcm11113078","journal-title":"J Clin Med"},{"key":"2258_CR40","doi-asserted-by":"publisher","first-page":"1344724","DOI":"10.3389\/fsurg.2023.1344724","volume":"10","author":"G Gallo","year":"2023","unstructured":"Gallo G, Dezi A, Grossi U, Picciariello A (2023) Sclerotherapy with 3% polidocanol foam in the treatment of hemorrhoidal disease: unveiling the missing pieces for a comprehensive evaluation. Front Surg 10:1344724","journal-title":"Front Surg"},{"key":"2258_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/codi.14498","volume":"21","author":"P Lobascio","year":"2019","unstructured":"Lobascio P, Minafra M, Laforgia R, Giove C, Trompetto M, Gallo G (2019) The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease\u2014a video vignette. Colorectal Dis 21:244\u2013245","journal-title":"Colorectal Dis"},{"key":"2258_CR42","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/codi.15613","volume":"23","author":"S Bracchitta","year":"2021","unstructured":"Bracchitta S, Bracchitta LM, Pata F (2021) Combined rubber band ligation with 3% polidocanol foam sclerotherapy (ScleroBanding) for the treatment of second-degree haemorrhoidal disease: a video vignette. Colorectal Dis 23:1585\u20131586","journal-title":"Colorectal Dis"},{"key":"2258_CR43","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/codi.15040","volume":"22","author":"A Skowronski","year":"2020","unstructured":"Skowronski A, Diaco E, Trompetto M, Gallo G (2020) Use of video-guided sclerotherapy with 3% polidocanol foam for symptomatic second-degree haemorrhoidal disease: a video vignette. Colorectal Dis 22:1198\u20131199","journal-title":"Colorectal Dis"},{"key":"2258_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/codi.17190","author":"G Gallo","year":"2024","unstructured":"Gallo G, Grossi U, Trompetto M, Diaco E, D\u2019Andrea V (2024) Digital platform for the treatment of II-III degree haemorrhoidal disease with 3% polidocanol foam: a video vignette. Colorectal Dis. https:\/\/doi.org\/10.1111\/codi.17190","journal-title":"Colorectal Dis"},{"key":"2258_CR45","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3748\/wjg.v30.i36.4021","volume":"30","author":"AG Rao","year":"2024","unstructured":"Rao AG, Nashwan AJ (2024) Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobanding. World J Gastroenterol 30:4021\u20134024","journal-title":"World J Gastroenterol"},{"key":"2258_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000493440","volume":"26","author":"B Rosa","year":"2019","unstructured":"Rosa B (2019) Polidocanol foam: a breath of fresh air for the treatment of internal hemorrhoids. GE Port J Gastroenterol 26:153\u2013154","journal-title":"GE Port J Gastroenterol"},{"key":"2258_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10151-023-02908-w","volume":"28","author":"G Gallo","year":"2024","unstructured":"Gallo G, Picciariello A, Armellin C, Lori E, Tomasicchio G, Di Tanna GL, Santoro GA, Alharbi M, Sorrenti S, Grossi U (2024) Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis. Tech Coloproctol 28:28","journal-title":"Tech Coloproctol"},{"issue":"1","key":"2258_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00384-023-04394-w","volume":"38","author":"J Patel","year":"2023","unstructured":"Patel J, McKechnie T, Wu K, Sharma S, Lee Y, Doumouras A, Hong D, Eskicioglu C (2023) Hemorrhoidal disease management with band ligation versus polidocanol sclerotherapy: a systematic review and meta-analysis (the HerBS Review). Int J Colorectal Dis 38(1):112. https:\/\/doi.org\/10.1007\/s00384-023-04394-w","journal-title":"Int J Colorectal Dis"},{"key":"2258_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1159\/000522171","volume":"29","author":"P Salgueiro","year":"2022","unstructured":"Salgueiro P, Ramos MI, Castro-Po\u00e7as F, Lib\u00e2nio D (2022) Office-based procedures in the management of hemorrhoidal disease: rubber band ligation versus sclerotherapy\u2014systematic review and meta-analysis. GE Port J Gastroenterol 29:409\u2013419","journal-title":"GE Port J Gastroenterol"},{"key":"2258_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/npmj.npmj_232_20","volume":"27","author":"A Makanjuola","year":"2020","unstructured":"Makanjuola A, Balogun OS, Osinowo AO, Adesanya AA, da Rocha JT (2020) Comparison of rubber band ligation with 3% polidocanol injection sclerotherapy for the treatment of internal haemorrhoids at a Nigerian tertiary hospital. Niger Postgrad Med J 27:311\u2013316","journal-title":"Niger Postgrad Med J"},{"key":"2258_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.978574","volume":"9","author":"G Lisi","year":"2022","unstructured":"Lisi G, Gentileschi P, Spoletini D, Passaro U, Orlandi S, Campanelli M (2022) Sclerotherapy for III- and IV-degree hemorrhoids: results of a prospective study. Front Surg 9:978574","journal-title":"Front Surg"},{"key":"2258_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10151-024-02998-0","volume":"28","author":"G Gallo","year":"2024","unstructured":"Gallo G, Lori E, Goglia M, Dezi A, Picciariello A, Grossi U (2024) Effectiveness of preoperative micronized purified flavonoid fraction treatment and sucralfate-based rectal ointment on hemorrhoidal disease: a case-matched analysis. Tech Coloproctol 28:126","journal-title":"Tech Coloproctol"},{"key":"2258_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.23736\/S1593-232X.24.00632-5","volume":"25","author":"M Goglia","year":"2024","unstructured":"Goglia M, Grossi U, D\u2019Andrea V, Gallo G (2024) A pilot study on the efficacy and safety of preoperative micronized purified flavonoid fraction treatment and sucralfate-based rectal ointment on patients with grade II to IV hemorrhoidal disease. Acta Phlebol 25:70\u201375","journal-title":"Acta Phlebol"},{"key":"2258_CR54","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00384-018-3046-2","volume":"33","author":"RR van Tol","year":"2018","unstructured":"van Tol RR, van Zwietering E, Kleijnen J, Melenhorst J, Stassen LPS, Dirksen CD, Breukink SO (2018) Towards a core outcome set for hemorrhoidal disease: a systematic review of outcomes reported in literature. Int J Colorectal Dis 33:849\u2013856","journal-title":"Int J Colorectal Dis"},{"key":"2258_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10151-022-02591-3","volume":"26","author":"L Dekker","year":"2022","unstructured":"Dekker L, Han-Geurts IJM, Grossi U, Gallo G, Veldkamp R (2022) Is the Goligher classification a valid tool in clinical practice and research for hemorrhoidal disease? Tech Coloproctol 26:387\u2013392","journal-title":"Tech Coloproctol"},{"key":"2258_CR56","doi-asserted-by":"publisher","unstructured":"Carvalho T, Leal T, Arroja B, Mesquita P, Malta I, Gago T, Gon\u00e7alves AR, Coelho R, Ponte SB, Salgueiro P, Castro-Po\u00e7as F, Bravo AC, Gouveia C, Oliveira AM, Francisco M, Gon\u00e7alves R, Caetano AC (2025) Efficacy and safety of office-based procedures for hemorrhoidal disease in patients with inflammatory bowel disease. Tech Coloproctol 29(1):111. https:\/\/doi.org\/10.1007\/s10151-025-03144-0. PMID: 40338393; PMCID: PMC12062045","DOI":"10.1007\/s10151-025-03144-0"}],"updated-by":[{"DOI":"10.1007\/s13304-025-02337-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000}}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02258-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:51:28Z","timestamp":1757487088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02258-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02258-2","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13304-025-02337-4","URL":"https:\/\/doi.org\/10.1007\/s13304-025-02337-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}